Semaglutide associated with dose-dependent weight loss and resolution of nonalcoholic steatohepatitis
1. Nonalcoholic steatohepatitis (NASH) resolution without worsening of fibrosis occurred in a significantly greater percentage of patients who received semaglutide ...